Bhilawa (Semecarpus anacardium L.f.) in Madhya Pradesh: An Integrated Field-Survey Investigation of Traditional Uses, Phytochemistry, Collection, Grading, Oil Extraction, Marketing and Safety

Semecarpus anacardium L.f., commonly known as Bhilawa or Bhallataka and also referred to as the marking nut tree, is a deciduous member of the family Anacardiaceae. The supplied review describes a tree approximately 12–14 m in height, with rough smoky dark-brown bark, smooth shiny leaves, greenish-yellow flowers and a characteristic heart-shaped drupe that changes from green to black during ripening. A fleshy, reddish, sweet-astringent hypocarp occurs at the base of the fruit. The species is distributed from the outer Himalayan tract through the hotter plains and is represented in several parts of central and peninsular India, including numerous forest divisions of Madhya Pradesh [1,2].

Bhilawa occupies a distinctive position in Indian ethnomedicine because the same phenolic-rich seed-coat oil associated with pharmacological activity can also produce marked irritation, vesication and contact dermatitis when raw material or concentrated oil is handled improperly. The research manuscript therefore frames Bhilawa as both a therapeutically valued folk remedy and a plant requiring careful handling and dose control. The integrated interpretation is especially relevant for forest-dependent communities in which collection, processing and traditional use are linked to household income and access to healthcare [1–4].

The supplied review further indicates that Bhilawa is not merely a medicinal raw material but a commercially important minor forest produce. Collection, grading, local trading, oil extraction and inter-state movement create a multi-stage value chain. In Madhya Pradesh, the field-survey material identifies Chhindwara, Betul, Bilaspur and Mandla as relatively high-producing areas and describes Chhindwara, Pendra, Betul, Katni and Jagdalpur as important trading centres. The traditional processing method documented at Prabhat Pattan in Betul is of particular research interest because it represents an indigenous oil-recovery technology developed around the chemical and handling characteristics of Bhilawa seed coat [2].

Phytochemically, the supplied sources describe a complex mixture of phenolic lipids and flavonoid constituents. Bhilawanols, anacardic acid, cardol, semecarpol and anacardol are associated with the seed-coat oil, whereas published phytochemical literature cited in the review identifies biflavonoids such as semecarpetin, jeediflavanone and tetrahydroamentoflavone, together with other classes including flavones, tannins, saponins, coumarins, alkaloids, glycosides, polyphenols, carotenoids, triterpenoids and steroids [3–7].

Accordingly, the objective of the present combined research article is not to reproduce the second manuscript as a review, but to use its botanical, chemical, technological and mechanistic material to strengthen the field-survey research paper. The resulting structure places the field-survey evidence and documented traditional practices at the centre, while the review-derived material is used to interpret those findings and to construct a coherent pharmacological and safety framework.

1.1 Objectives of the Study

1. To document the botanical identity, morphology, distribution and vernacular nomenclature of Semecarpus anacardium L.f. from the supplied field-survey and literature sources.
2. To consolidate field-survey information on Bhilawa collection, grading, seasonal maturity, storage and marketing in Madhya Pradesh.
3. To document the traditional seed-coat oil-extraction technology reported from Prabhat Pattan, Betul, and its occupational handling practices.
4. To compile the proximate/nutritional composition and principal phytochemical constituents of Bhilawa seed, kernel and seed-coat oil.
5. To document the traditional therapeutic applications and parts/preparations used by communities represented in the supplied field-survey material.
6. To integrate published pharmacological evidence into a proposed mechanism linking Bhilawa constituents with antioxidant, anti-inflammatory, antigout, anticancer, hypolipidaemic and antimicrobial effects.
7. To consolidate the documented adverse effects, precautionary practices and prevention/management framework associated with Bhilawa use.
8. To clearly distinguish verified/source-derived field-survey information from the simulated numerical datasets included in the original research manuscript.

2. MATERIALS AND METHODS

2.1 Study Design

The present manuscript is a combined field-survey-based research article prepared from two supplied source documents: (i) a research manuscript focused on traditional therapeutic uses and prevention of Bhilawa-associated adverse effects, and (ii) a comprehensive review containing botanical, phytochemical, collection, grading, oil-extraction, marketing and pharmacological information. The field-survey information is treated as the primary descriptive research component, while published literature contained in the supplied review is used for scientific interpretation.

The original research manuscript explicitly states that it combines source field-survey information with a clinical-observation component. Because the numerical clinical/adverse-event values were labelled simulated in the source, they are not treated as actual patient outcomes in this integrated paper. They are retained only in a separate illustrative section so that the original dataset is not silently converted into clinical evidence [1].

2.2 Field-Survey Data Source

The supplied manuscripts describe structured interviews and direct observation involving collectors, traders and users in major Bhilawa-producing areas of Madhya Pradesh. The documented variables include vernacular names, botanical description, collection practice, grading, oil-extraction technology, marketing/distribution and traditional therapeutic indications. The exact number of field-survey respondents and a complete sampling frame are not specified in the supplied documents; therefore, no additional sample size is invented in this paper.

2.3 Botanical and Ethnobotanical Documentation

Botanical characteristics, taxonomic identity, regional names and distribution were compiled directly from the supplied review. Traditional uses were organised according to plant part, preparation and reported indication. The accepted scientific name used throughout this paper is Semecarpus anacardium L.f., as given in the supplied review [2,8].

2.4 Collection, Grading and Marketing Assessment

Collection practices, estimated annual production, district-wise production pattern, grading criteria, market prices, trader volumes and distribution pathways were transcribed from the field-survey data presented in the supplied review. Grading was interpreted using the documented seed-coat colour, water-flotation behaviour, kernel colour and maturity criteria.

2.5 Traditional Oil-Extraction Technology

The traditional extraction technology was documented from the field-survey account of Prabhat Pattan (Betul district, Madhya Pradesh), with comparison to the related larger-scale practice described for Akola, Maharashtra. The process involves placing seed coat/peel in an inverted earthen pot over a second collection pot sunk into a pit and heating the assembly with burning coal so that phenolic oil drains into the lower vessel [2]. The associated protective practice of polythene and cloth covering during kernel processing was also retained.

2.6 Phytochemical and Pharmacological Synthesis

Phytochemical and pharmacological information was consolidated from the references already cited in the supplied review and research manuscript. Particular attention was given to bhilawanols, anacardic acid, cardol, semecarpol, anacardol and biflavonoids, and to the mechanisms described for antioxidant activity, xanthine oxidase inhibition, apoptosis, hypolipidaemia and antimicrobial effects [3–7,11–19]. Where the supplied review proposes a molecular mechanism by analogy with related biflavonoid systems, this paper explicitly describes it as a proposed or inferred mechanism rather than a confirmed Semecarpus-specific pathway.

2.7 Treatment of the Simulated Numerical Dataset

The original research manuscript contains three quantitative groups of simulated data: (a) n=120 simulated responses for traditional-use frequency, (b) simulated adverse-event frequencies under three precaution-adherence groups, and (c) simulated mean resolution times under four first-aid regimens. These values were explicitly identified in the source as  and are therefore presented in Section 3.9 as illustrative methodological data only. They must not be cited as clinical evidence or as verified epidemiological findings.

3. RESULTS

3.1 Taxonomic and Botanical Profile

Table 1. Taxonomic and botanical profile of Semecarpus anacardium L.f. [2,8].

Figure 1. Bhilawa fruit clusters (green, unripe drupes)

3.2 Vernacular Names Across India

Table 2. Vernacular names of Bhilawa reported across Indian regions [2].

3.3 Chemical and Nutritional Composition

The field-survey chemical analysis reproduced in the supplied review reports a relatively high fat and protein content in the seed kernel. The values below are presented as source-reported field-survey composition and should be treated as such until independently revalidated using a standard analytical protocol.

Table 3. Proximate and biochemical composition of Bhilawa seed kernel reported in the supplied field-survey review [2,11].

Figure 2. Approximate proximate composition of Bhilawa seed kernel per 100 g

Figure 3. Traditional inverted-pot pit distillation method for extraction of Bhilawa seed-coat oil

Figure 4. Marketing and distribution chain of Bhilawa seed from rural collector to end consumer in Madhya Pradesh

Table 6. Socio-economic and marketing indicators reported in the supplied Madhya Pradesh field-survey review [2].

Indicator	Value reported in supplied field-survey review
Total annual collection	≈ 23,650 quintals
Share of total production traded	75–80%
Average per-trader seasonal trade volume	≈ 276 quintals
Average per-trader seasonal expenditure	≈ ₹71,000
Estimated annual state trade value	> ₹80 lakh
Local collector's realised share of market price	≈ 46%
Middlemen/traders' share of price margin	≈ 54%
Bhilawa price, Madhya Pradesh tribal sale rate	₹150–200 per quintal
Bhilawa price, Maharashtra tribal sale rate	₹500–600 per quintal
Historical seed price (1995–96)	₹200–1,000 per quintal
Historical kernel price (1995–96)	₹14,000–16,000 per quintal

Figure 5. Proposed integrated mechanism of pharmacological action of Bhilawa bioactive constituents

Figure 7.  frequency of reported traditional uses of Bhilawa among n=120 simulated respondents

Table 9. Simulated traditional-use frequency dataset from the original research manuscript (n=120).

Indication	Part/preparation used	Reported frequency (%) –simulated
Arthritis / joint pain	Whole seed boiled in tea/milk	78
Gout	Whole seed decoction	52
Indigestion / gas	Whole seed boiled in tea/sugar water	64
Diarrhoea / piles	Seed/peel smoke fumigation	41
Skin disease / leukoderma	Oil, topical	58
Insect / snake bite	Oil, topical ± oral drops in milk	36
Respiratory ailments	Oil in tea; ash of burnt seed with honey	47
Wound / cracked heel	Oil, topical	61
Post-partum weakness / lactation support	Kernel boiled with jaggery/milk	33
Veterinary use (cattle)	Whole seed with roti/jaggery; oil on hooves	44

Figure 8.  adverse-event incidence by precaution adherence

Table 10. Simulated adverse-event dataset from the original research manuscript.

Precaution-adherence group	Mild AE (%)	Moderate AE (%)	Severe AE (%)	Overall AE (%)
Precautions fully followed	22	3	0	25
Precautions partially followed	38	14	2	54
No precautions followed	46	29	9	84

Figure 9.  mean time to resolution of Bhilawa-oil-induced dermal irritation under different first-aid measures

Table 11. Simulated first-aid resolution-time dataset from the original research manuscript.

4. DISCUSSION

The integrated findings place Bhilawa at the intersection of ethnopharmacology, indigenous processing technology and rural forest-based livelihoods. The botanical profile and broad vernacular nomenclature indicate longstanding recognition across different regions of India. The field-survey data further demonstrate that Bhilawa collection is not an isolated medicinal activity but part of a larger minor-forest-produce economy involving collectors, village traders, mandis, processors, inter-state wholesalers and end users [2].

The grading criteria are particularly relevant to the research interpretation because they connect physical characteristics with economic value. Dark-black, well-filled, heavy seeds with milky-white kernels and appropriate maturity are considered higher grade, whereas immature or poorly filled material is assigned lower grade. The supplied review suggests that premature harvesting is driven partly by short-term income needs, but this practice can reduce quality and price realisation. Thus, scientific collection training and regulated maturation could improve both raw-material quality and collector income.

The traditional oil-extraction process is one of the most distinctive elements of the combined study. The inverted-pot pit distillation arrangement demonstrates an indigenous approach to recovering the phenolic oil from a material that is hazardous to handle directly. The occupational use of polythene and cloth protection further illustrates how local processing knowledge has incorporated practical risk reduction. At the same time, the historical use of Bhilawa oil in paint manufacture generated environmental concerns because of fumes; the supplied review therefore recommends emission-control technology if such processing is revived [2].

The phytochemical profile provides a plausible biochemical bridge between traditional uses and pharmacological activity. Phenolic compounds and biflavonoids can contribute antioxidant effects, while the reported xanthine-oxidase inhibition of tetrahydroamentoflavone provides a more specific mechanistic explanation for the traditional association with gout. The proposed anticancer mechanisms are more tentative because some pathway details are inferred from biflavonoid systems outside direct Semecarpus-specific experiments. This distinction is important for a research article: a mechanistic hypothesis should not be written as a clinically established mechanism [12,17,18].

The safety findings also require careful interpretation. The research manuscript's simulated n=120 data show a numerical gradient in adverse-event frequency according to precaution adherence and a shorter simulated resolution time with camphorated coconut/sesame oil. However, these values are explicitly hypothetical. The appropriate research conclusion is therefore not that the intervention has been clinically proven, but that the field-survey-derived prevention practices form a testable hypothesis that warrants controlled dermatological and toxicological evaluation.

The socio-economic data suggest that value addition could be as important as pharmacological development. If collectors receive only a fraction of the final market value, improved grading, storage, organised procurement and direct market access could increase local benefit without increasing harvesting pressure. The supplied review also identifies poverty, illiteracy, weak institutional capacity and loss of urban industrial demand as important barriers to value realisation [2].

5. LIMITATIONS

The supplied field-survey manuscripts do not provide a complete respondent-level dataset, sampling frame, dates, questionnaire or statistical analysis plan; these should be added from the original field records before journal submission.

The n=120 traditional-use frequencies, adverse-event frequencies and first-aid resolution times in the research manuscript are explicitly simulated and must not be presented as verified clinical or epidemiological evidence.

Several bibliographic entries in the supplied manuscripts are incomplete (for example, some journal volume/page details are absent); the reference list below preserves the supplied source information and should be bibliographically verified before submission.

Some proposed molecular mechanisms, particularly the complete apoptosis-signalling pathway, are described in the supplied review by analogy with related biflavonoid systems; they require direct Semecarpus-specific validation.

The proximate composition values are reported as field-survey data and should be independently confirmed using validated analytical methods before being used for quantitative nutritional claims.

6. CONCLUSION

The combined field-survey research demonstrates that Semecarpus anacardium L.f. is simultaneously a medicinal plant, a minor forest produce species, an indigenous-processing resource and a source of livelihood for forest-dependent communities. The integrated dataset documents a recognisable botanical identity, diverse vernacular nomenclature, broad distribution in Madhya Pradesh, defined traditional grading practices, a distinctive inverted-pot oil-extraction technology and a multi-stage marketing chain. Its phytochemical profile is dominated by phenolic and biflavonoid constituents that provide plausible mechanistic bases for antioxidant, anti-inflammatory, antigout, anticancer, hypolipidaemic and antimicrobial activities.

At the same time, the same phenolic oil fraction creates a genuine safety challenge through dermal irritation, vesication and potential exposure to processing fumes. The integrated research therefore supports a prevention-oriented approach based on protective handling, controlled traditional use, improved processing conditions, scientific grading, organised marketing and formal validation of pharmacological and safety claims. The simulated numerical datasets retained from the original research manuscript should be treated only as methodological illustrations until replaced by verified field or clinical data.

7. RECOMMENDATIONS FOR FURTHER RESEARCH

Conduct a prospective, ethically approved field study with a defined sampling frame to quantify traditional-use prevalence and safety outcomes.

Standardise the traditional Bhilawa oil-extraction process and determine yield, physicochemical properties and batch-to-batch variation.

Perform validated chromatographic profiling of bhilawanols, anacardic acids, cardol, semecarpol, anacardol and biflavonoids.

Evaluate antioxidant activity using validated in-vitro assays and correlate activity with total phenolic/flavonoid content and chemical markers.

Directly test the proposed xanthine-oxidase, inflammatory and apoptosis-related mechanisms in Semecarpus-specific experimental models.

Characterise occupational exposure during traditional oil extraction and develop engineering controls and personal protective measures.

Assess the effect of scientific grading, regulated maturation, storage and direct market access on collector income and raw-material quality.

Replace the simulated n=120 datasets in the original research manuscript with verified observations before any clinical or epidemiological inference is made.

REFERENCES

1. Bais AG, Hiradeve SM, Uplanchiwar VP. Semecarpus anacardium Linn: an ethnomedical, phytochemical and pharmacological review. Int J Pharm Sci Res. 2013;4(1):9-17.
2. Premalatha B. Semecarpus anacardium Linn. nuts—a boon in alternative medicine. Indian J Exp Biol. 2000;38(12):1177-82.
3. Deepa N, Vijay V, Uthanthi TU, Faustina TM, ThamizhKuil RV, Vasundra K, et al. Semecarpus anacardium: a review of its phytochemistry, traditional uses, pharmacological and toxicological properties. Int J Pharm Biol Sci. 2024;14(3).
4. Semecarpus anacardium Linn.: a review. Pharmacogn Rev. 2010;4(7):88-94.
5. Mishra AK, S NL, Jain A. Effectiveness of Semecarpus anacardium Linn. fruits in cancer and inflammatory diseases: a mini review. S Afr J Bot. 2024.
6. Gedam PH, Sampathkumaran PS, Sivasamban MA. Composition of bhilawanol from Semecarpus anacardium. Phytochemistry. 1973;12(3):671-81.
7. Indap MA, Ambaye RY, Gokhale SV. Anti-tumour and pharmacological effect of oil from Semecarpus anacardium Linn. Indian J Physiol Pharmacol. 2008;2:9-13.
8. Ishratullah K, Ansari WH, Rahman W, Okigawa M, Kawano N. Bioflavanoids from Semecarpus anacardium Linn. Indian J Chem. 1971;9:1044.
9. A review on Semecarpus anacardium Linn. Nirma Univ J Pharm Sci. 2019;6(1).
10. Semecarpus anacardium [Internet]. Wikipedia, The Free Encyclopedia. [cited 2026 Aug 21]. Available from: https://en.wikipedia.org/wiki/Semecarpus_anacardium
11. Semecarpus anacardium L.f. [Internet]. Plants of the World Online, Royal Botanic Gardens, Kew. [cited 2026 Aug 21]. Available from: https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:71196-1
12. Rakesh K, et al. Isolation of tetrahydroamentoflavone from Semecarpus anacardium seed as a xanthine oxidase inhibitor for gout and inflammation. Phytochemistry. 2001.
13. Huang H, Hao J, Pang K, Lv Y, Wan D, Wu C, et al. A biflavonoid-rich extract from Selaginella moellendorffii Hieron. induces apoptosis via STAT3 and Akt/NF-κB signalling pathways in laryngeal carcinoma. J Cell Mol Med. 2020;24(17):9520-31.
14. Rahman KM, Rahman MS, Rashid Begum B. Preliminary cytotoxicity screening of some medicinal plants of Bangladesh. Dhaka Univ J Pharm Sci. 2008;7(1):47-52.
15. Virtual screening of MAP-Tau protein inhibitors from Semecarpus anacardium Linn. leaf extract for cancer prevention. bioRxiv. 2020.
16. Rakesh KA, et al. Chloroxylon swietenia (Roxb.) DC induces cell death and apoptosis by down-regulating the NF-κB pathway in MCF-7 breast cancer cells: in vitro and in vivo investigations. Front Pharmacol. 2022.
17. Sharma A, Verma PR, Itankar PR, Arora SK. Antiatherogenic and hypolipidemic effect of Semecarpus anacardium nut milk extract. Int J Pharm Toxicol. 2008.
18. A brief review of Semecarpus anacardium Linn. Int J Pharm Sci (IJPS Journal). 2025.
19. A review on Semecarpus anacardium: pharmacological properties, therapeutic potential, and traditional uses. Int J Pharm Sci (IJPS Journal). 2025.